Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subject: CON

MJH Life Sciencestm Adds International Society for Vaccines to its Strategic Alliance Partnership


CRANBURY, N.J., April 15, 2021 /PRNewswire/ -- MJH Life Sciencestm is proud to announce an official partnership with the International Society for Vaccines (ISV) by adding them to its Strategic Alliance Partnership (SAP) program. This prestigious organization will strengthen MJH's portfolio in the primary and specialty care markets by collaborating with ContagionLive®, Contemporary Pediatrics®, HCPLive®, and Infection Control Today.

This prestigious organization will strengthen MJH's portfolio in the primary and specialty care markets.

"We are very honored to join forces with a remarkable organization like the ISV," said Mike Hennessy Jr., president and CEO of MJH Life Sciencestm. "This new partnership between each of our premier brands and the ISV will be extremely effective in creating an environment in which we can share ideas, information, techniques, research and more. I am looking forward to seeing what amazing initiatives arise from our collaboration."

The ISV encourages, establishes, and promotes the development and use of vaccines and immunity to prevent and control infectious and noninfectious diseases in humans and animals. Comprising leaders from the global research and scientific community, ISV has cultivated a robust academic and professional membership. Led by an esteemed board of directors and officers, the organization delivers trusted information to its audience of more than 700 members in almost 40 countries.

In addition to hosting an annual congress, ISV has also hosted several virtual events, including a COVID-19 vaccine series.

"ISV is pleased to team up with MJH to develop and provide much-needed education materials focusing on vaccines and related areas for its wide audience of medical professionals," said Shan Lu, M.D., Ph.D., board member and treasurer of ISV.

Last month, the MJH Life Sciencestm COVID-19 Coalition and ISV co-hosted a free, live 90-minute webinar titled "Building Confidence in COVID-19 Vaccination: A Toolbox of Talks from Leaders in the Field," which featured a panel of world-renowned professionals discussing the key issues driving vaccine hesitancy and how scientists and health care professionals can address that mindset. The program is available on demand here.

The SAP program provides medical associations, health plans, advocacy groups and medical institutions with a national reach and visibility. By using the MJH Life Sciencestm communications platform, partners can showcase cutting-edge initiatives, content, research, and thought leadership. SAP fosters collaboration and the open exchange of information among trusted peers for the benefit of patients and their families. As part of this joint effort, ContagionLive®, Contemporary Pediatrics®, HCPLive®, and Infection Control Today®, will work closely with ISV on content pieces, create virtual programming, develop clinician educational materials on vaccination, and further elevate the field of vaccinology to our audience of health care professionals. 

For a full list of ContagionLive® SAP partners, click here.

For a full list of Infection Control Today® SAP partners, click here.

For a full list of  HCPLive® SAP partners , click here.

For more information on Contemporary Pediatrics®, click here.

For more information on the International Society for Vaccines, click here.

About MJH Life Sciencestm

MJH Life Sciencestm is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.

MJH Life Sciencestm Media Contact
Alexandra Ventura, 609-716-7777
[email protected]

SOURCE MJH Life Sciences


These press releases may also interest you

at 12:20
The "Global Influencer Marketing Platform Market: Analysis By Component, By Application, By Organization Size, By End Use, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 11:55
The "COVID-19 Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global COVID-19 Vaccines Market to Reach 4.2 Billion Doses by 2025 The global market for COVID-19 Vaccines, estimated at 6.4 Billion...

at 10:55
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
The "Global High-Altitude Aeronautical Platform Station (HAAPS) Market: Focus on Type, Frequency Band, Subsystem, Application, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...

at 10:20
The "Airport Robots Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The airport robots market has grown rapidly in recent years. It will grow from $1.29 billion in 2023 to $1.5 billion in 2024 at a compound...



News published on and distributed by: